Capstone Investment Advisors »

Heron Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $45k 23k 1.99

More positions owned by Capstone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon Call Option (AMZN)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)

View all positions for Capstone Investment Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Vanguard Group
BlackRock
BlackRock
Tejara Capital
State Street Corporation
D. E. Shaw & Co
Palisade Capital Management
Geode Capital Management
JW Asset Management
Clearline Capital
Renaissance Technologies
Orchard Capital Managment
Congress Park Capital
Tang Capital Management

View all funds holding Heron Therapeutics